Kathmere Capital Management LLC Cuts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Kathmere Capital Management LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 14.5% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,810 shares of the healthcare conglomerate’s stock after selling 646 shares during the quarter. Kathmere Capital Management LLC’s holdings in UnitedHealth Group were worth $1,885,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Richelieu Gestion SA purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at $26,000. CGC Financial Services LLC increased its holdings in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the last quarter. True Wealth Design LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at $31,000. LFA Lugano Financial Advisors SA increased its holdings in UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 40 shares during the last quarter. Finally, Transcendent Capital Group LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $40,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 4.8 %

Shares of NYSE:UNH opened at $509.58 on Friday. The company has a market capitalization of $469.01 billion, a PE ratio of 31.15, a P/E/G ratio of 1.41 and a beta of 0.58. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The firm has a 50 day simple moving average of $498.34 and a 200-day simple moving average of $502.27.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the company posted $6.26 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.57 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were paid a $2.10 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s payout ratio is currently 51.34%.

Analyst Ratings Changes

Several equities analysts recently commented on UNH shares. Barclays upped their price target on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Robert W. Baird initiated coverage on shares of UnitedHealth Group in a research report on Thursday, May 30th. They issued an “outperform” rating and a $597.00 price target for the company. Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday. Finally, JPMorgan Chase & Co. increased their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research report on Thursday, May 30th. Three equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $579.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.